Corbus Pharmaceuticals Holdings, Inc. Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 1.25% for the 6-month period ending 2014-06-30, per its 10-K filed 2016-03-28.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2016-03-28
- Corbus Pharmaceuticals Holdings, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2014-03-31 was 1.40%.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 6 month |
|---|---|---|---|
| 2014-06-30 | 1.25% 10-K · filed 2015-02-10 | 1.25% 10-K · filed 2016-03-28 | |
| 2014-03-31 | 1.40% 10-Q · filed 2015-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |